Dexa Group

dexagroup logo hut 55 en

Stronger, Smarter

For more than five decades, Dexa Group has been committed to the promotion of health through the safety, quality, and efficacy of medicinal products.

From Molecule, to Market

Building end-to-end competency in pharmaceutical discovery, formulation, manufacturing, and marketing across four continents: Asia, Africa, Europe, and America.

Dexa means Quality

Our name was inspired by the Greek δέκα, meaning 10 — a universal symbol of perfection. Even today, our work aspires to that same impossible standard. That’s why, for millions of people in 14 countries, Dexa means quality.

Indonesian Modern Herbal Medicines

We identify, extract, and test biomolecules embedded deep in nature. Then, we use these microscopic gems to produce herbal medicines that are extraordinarily safe and effective.

Dexa: A Snapshot




Pharmacies Covered Directly

International Alliances

Marketing Authorisations

Latest News

8 July 2024

⁠Ferron Partners with PERKENI for 2024 CVM Summit and Unveils New Diabetes Treatment

PT Ferron Par Pharmaceuticals, in collaboration with the Indonesian Society of Endocrinology (PERKENI), held the Cardio-Vascular Metabolic (CVM) Summit titled "1st Ferron CVM Summit." During the event, Ferron launched its latest anti-diabetes product, Fliptin. The event was attended by Dexa Group CEO, Mr. Ferry Soetikno; Dexa Group President Commissioner, Mrs.…
6 June 2024

Implementation of “Deal with Care”: Dexa Group Donates Ambulance to Puskesad Health Education Center

Dexa Group has enhanced its corporate value of "Deal with Care" by donating an ambulance to the Army Health Education Center (Pusdikkes Puskesad) to improve healthcare services for the community around the Pusdikkes Puskesad Hospital. Mr. V Hery Sutanto, the leader of Dexa Medica, handed over the ambulance to Colonel…
30 May 2024

Dexa Group advocates for the development of traditional herbal medicine through Indonesia Indigenous Modern Medicine in the webinar titled “Jamu: Dulu, Kini, dan Nanti.”

Indonesia's potential wealth in natural resources, as the second-largest country in terms of biodiversity, boasting over 28 thousand species of plants and 2,848 medicinal plants, presents significant opportunities for the development of natural medicine and Indonesia Indigenous Modern Medicine (OMAI) phytopharmaceuticals. Dra. Reri Indriani, Senior Expert Pharmacist and Food Supervisor…
28 May 2024

Encouraging the Development of Phytopharmaca, Dexa Group Participates in the National Jamu Week Event by BPOM.

Dexa Group is a research-based pharmaceutical company committed to actively participating in developing phytopharmaca. This commitment aligns with the government's efforts to address the dependency on imported raw materials for medicines by utilizing the country's natural resources to produce phytopharmaca. "The government provides full support for developing medicines, including natural…
23 April 2024

Prof. Raymond Tjandrawinata, The Pioneer of Indonesia’s Indigenous Modern Medicine, Ranks Among The Top Three Pharmaceutical Scientists

Clinical and Molecular Pharmacologist Prof. Raymond Tjandrawinata of Dexa Group and Unika Atma Jaya, who also pioneers the development of Indonesia Indigenous Modern Medicine (OMAI), has achieved third place among the top pharmaceutical scientists in Indonesia. The AD Scientific Index provided this ranking based on a system that analyzes scientific…
8 April 2024

Implementation of ESG, Dexa Group Supports Research Facility at Rumah Perubahan

To encourage sustainable environment and implement Environmental, Social, and Governance (ESG) principles, Dexa Group supports research facilities at Rumah Perubahan by providing microscopes. The microscopes were presented by Dexa Group's Business Development and Scientific Affairs Director, Prof. Raymond Tjandrawinata, to the Founder of Rumah Perubahan, Prof. Rhenald Kasali on Friday,…